Page last updated: 2024-10-22

acetazolamide and Aldosteronism with Hyperplasia of the Adrenal Cortex

acetazolamide has been researched along with Aldosteronism with Hyperplasia of the Adrenal Cortex in 1 studies

Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Research Excerpts

ExcerptRelevanceReference
"We randomly assigned children with Bartter syndrome in a 1:1 ratio to either receive indomethacin, enalapril, and spironolactone or indomethacin, enalapril, and spironolactone plus acetazolamide once daily in the morning for 4 weeks."2.94Adjunctive acetazolamide therapy for the treatment of Bartter syndrome. ( Assadi, F; Mazaheri, M; Sadeghi-Bojd, S, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mazaheri, M1
Assadi, F1
Sadeghi-Bojd, S1

Trials

1 trial available for acetazolamide and Aldosteronism with Hyperplasia of the Adrenal Cortex

ArticleYear
Adjunctive acetazolamide therapy for the treatment of Bartter syndrome.
    International urology and nephrology, 2020, Volume: 52, Issue:1

    Topics: Acetazolamide; Antihypertensive Agents; Bartter Syndrome; Carbonic Anhydrase Inhibitors; Child, Pres

2020